<?xml version="1.0" encoding="UTF-8"?>
<p>During the acute phase, there were no significant (2-fold) differences in the mRNA expression levels of immune mediators in fatal patients versus survivors. Moreover, of the 84 analyzed factors, 16 (19%) showed ≥2-fold variation in gene expression in fatal as compared to the survivor group, specifically an upregulation of up to &gt;3/4-fold was seen for 
 <italic>CSF1</italic>, 
 <italic>CXCL1</italic>, 
 <italic>IL-6</italic>, 
 <italic>CXCL8</italic> and 
 <italic>SPP-1</italic> cytokines (
 <xref ref-type="fig" rid="viruses-11-00373-f001">Figure 1</xref>a–c).
</p>
